Panagora Asset Management Inc Innoviva, Inc. Transaction History

Panagora Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$12.37 - $13.89 $172,190 - $193,348	13,920 New	13,920 $180,000
Q1 2023 May 11, 2023	BUY	$10.73 - $13.6 $299,613 - $379,752	27,923 New	27,923 $314,000
Q1 2020 May 14, 2020	SELL	$8.11 - $15.23 $4,728 - $8,879	-583 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$13.1 - $14.95 $1.85 Million - $2.11 Million	-141,343 Reduced 99.59%	583 $8,000
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $66,355 - $97,230	-4,847 Reduced 3.3%	141,926 $1.99 Million
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $75,802 - $99,151	5,430 Added 3.84%	146,773 $2.56 Million
Q3 2018 Nov 13, 2018	BUY	$13.63 - $15.7 $1.93 Million - $2.22 Million	141,343 New	141,343 $2.15 Million

228

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.2B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.